Related Articles
Targeted therapy for gastric cancer: Current status and future directions (Review)
Correlation between human epidermal growth factor receptor 2 expression level and efficacy of trastuzumab beyond progression in metastatic gastric cancer
Immune checkpoint inhibitor combination therapy for gastric cancer: Research progress (Review)
Apatinib combined with trastuzumab and albumin‑bound paclitaxel for treatment of HER2+ breast cancer with brain metastases resistant to anti‑HER2 TKIs: A case report
Unraveling trastuzumab and lapatinib inefficiency in gastric cancer: Future steps (Review)